Prostate Disorders Clinical Trials

A listing of Prostate Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 335 clinical trials
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer

The aim of this study is to test the safety and feasibility of SBRT without ADT in oligometastatic prostate cancer in patients for whom the standard treatment is ADT, and to further explore how

  • 0 views
  • 04 Oct, 2022
  • 1 location
Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection

This study was conducted to compare the effects of intrathecal versus intravenous dexmedetomidine administration in patients undergoing Transurethral resection of the prostate under spinal

  • 0 views
  • 07 Oct, 2022
  • 1 location
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer (BLAST)

This is a single-arm, open-label study using pacritinib for patients with histologically confirmed prostate adenocarcinoma, status post definitive treatment and biochemical recurrence.

  • 0 views
  • 04 Oct, 2022
  • 1 location
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

This exploratory study conducted under the RDRC program studies the biodistribution of 99mTc-PSMA-I&S in patients with prostate cancer who undergo pelvic lymph node dissection. Prostate

  • 0 views
  • 04 Oct, 2022
  • 1 location
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

This phase IIa trial investigates how well apalutamide before surgery works in treating patients with prostate cancer that is confined to the prostate gland. Testosterone can cause the growth of

  • 0 views
  • 07 Oct, 2022
  • 3 locations
Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiographic progression, intolerable toxicity, or patient/physician wishes to discontinue protocol therapy. A maximum of 35 cycles may be administered. On Day 1, when both pembrolizumab and lenvatinib are …

  • 0 views
  • 04 Oct, 2022
  • 1 location
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

This is a double-blinded, placebo-controlled randomized phase II clinical trial investigating whether flibanserin promotes sexual interest in men with prostate cancer who are receiving androgen

  • 0 views
  • 04 Oct, 2022
  • 1 location
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

(treatment naive) for high risk prostate cancer that is sensitive to androgen deprivation therapy (castration sensitive) and has spread to other parts of the body (metastatic). This study also aims to

androgens
prednisone
androgen ablation
docetaxel
antiandrogen therapy
  • 0 views
  • 04 Oct, 2022
  • 1 location
68Ga-PSMA-11 PET in Patients With Prostate Cancer

This trial studies how well 68Ga-PSMA-11 PET/CT scan works in imaging patients with prostate cancer. Diagnostic procedures, such as 68Ga-PSMA-11 PET/CT may find and diagnose prostate cancer and

  • 0 views
  • 13 Oct, 2022
  • 1 location
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer

One of the usual approaches to treating intermediate-risk prostate cancer is a type of radiation therapy called SBRT (stereotactic body radiation therapy). SBRT delivers higher than standard

  • 0 views
  • 07 Oct, 2022
  • 7 locations